Due to our finding that the effect of SNAP25 protein on survival prognosis became more pronounced as the pathological grading of prostate patients became more advanced, the SNAP25 protein was validated as a prognostic biomarker and selected for further analysis. This evidence concerns the gene SNAP25 and male reproductive organ cancer.